Traws Pharma, Inc. Net Income Loss

• Traws Pharma, Inc. showed a decrease of -778.8% in Net Income Loss from 2023 to 2024.
• This data is from Traws Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
• XBRL data for this metric is available from 2011 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 11 years of available data (2011 to 2024), Traws Pharma, Inc.'s Net Income Loss has declined by 533.3%.
• Historical annual values: Fiscal year 2024: -$166.52 million | Fiscal year 2023: -$18.95 million | Fiscal year 2019: -$21.50 million | Fiscal year 2018: -$20.57 million | Fiscal year 2017: -$24.09 million | Fiscal year 2016: -$19.67 million | Fiscal year 2015: -$23.98 million | Fiscal year 2014: -$63.68 million | Fiscal year 2013: -$62.54 million | Fiscal year 2012: -$29.91 million | Fiscal year 2011: -$26.29 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026